for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. pauses distribution of Lilly's COVID-19 antibody therapies

June 25 (Reuters) - U.S. health officials on Friday paused the distribution of Eli Lilly’s COVID-19 antibody therapies - bamlanivimab and etesevimab together and etesevimab alone - as they fail to show effectiveness against the Brazil and South Africa variants of the coronavirus. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up